Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Lancet Gastroenterol Hepatol. 2019 Apr 10;4(6):435–444. doi: 10.1016/S2468-1253(19)30085-8

Figure 3:

Figure 3:

Map of Population Attributable Fraction (tPAF) of HCV transmission due to the risks associated with IDU from 2018–2030. This was calculated as the percentage of all new HCV infections that would be prevented over 2018–2030 if the additional transmission risk due to IDU was removed over this period. Countries in grey were not modelled due to a lack of data.

HHS Vulnerability Disclosure